| 000 | 01620 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515091117.0 | ||
| 264 | 0 | _c20080201 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAppel, Heiner | |
| 245 | 0 | 0 |
_aIn vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitis. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cNov 2007 |
||
| 300 |
_a2264-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aAntigens, Bacterial |
| 650 | 0 | 4 | _aAntigens, Viral |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 |
_aEnterotoxins _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _ximmunology |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aScheer, Rebecca | |
| 700 | 1 | _aHaibel, Hildrun | |
| 700 | 1 | _aWu, Peihua | |
| 700 | 1 | _aSpiller, Inge | |
| 700 | 1 | _aBrandt, Henning | |
| 700 | 1 | _aSong, In-Ho | |
| 700 | 1 | _aRudwaleit, Martin | |
| 700 | 1 | _aThiel, Andreas | |
| 700 | 1 | _aSieper, Jochen | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 34 _gno. 11 _gp. 2264-70 |
|
| 999 |
_c17440145 _d17440145 |
||